Image
Evidence-Based Best Practices

Clinical Updates on the Management of Gout

Evidence-Based Strategies for Improved Patient Outcomes

Meeting Slides

Clinical Tools

2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.

Khanna D, et al. Arthritis Care Res (Hoboken). 2012;64(10):1431-1446.

2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis.

Khanna D, et al. Arthritis Care Res (Hoboken). 2012;64(10):1447-1461.

Evolution of management of gout: a comparison of recent guidelines

Khanna PP, FitzGerald J. Curr Opin Rheumatol. 2015;27(2):139-146.

Educational Materials for Patients and Their Families

What Is Gout? Fast Facts: An Easy-to-Read Series of Publications for the Public

A brochure in simplified language from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health

Gout

Patient brochure from the American Colllege of Rheumatology

Gout Education for Patients

Patient information from the Gout & Uric Acid Education Society

Suggested Readings

The Emerging Role of Biotechnological Drugs in the Treatment of Gout.

Cavagna L, Taylor WJ. BioMed Res Int. 2014. doi: 10.1155/2014/264859. Epub 2014 Apr 16.

Imaging in gout: a review of the recent developments.

Chowalloor PV, et al. Ther Adv Musculoskelet Dis. 2014;6(4):131-143.

New medications in development for the treatment of hyperuricemia of gout.

Diaz-Torné C, et al. Curr Opin Rheumatol. 2015;27(2):164-169.

Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia.

Fleischmann R, et al. Rheumatology. 2014;53(12):2167-2174.

The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality.

Gustafsson D, Unwin R. BMC Nephrology. 2013;14:164.

Emerging therapies for gout.

Edwards NL, So A. Rheum Dis Clin North Am. 2014;40(2):375-387.

The association of gout with socioeconomic status in primary care: a cross-sectional observational study.

Hayward RA, et al. Rheumatology (Oxford). 2013;52(11):2004-2008.

The crystallization of monosodium urate.

Martillo MA, et al. Curr Rheumatol Rep. 2014;16(2):400. doi:10.1007/s11926-013-0400-9.

Racial and gender disparities in patients with gout.

Singh JA. Curr Rheumatol Rep. 2013;15(2):307. doi:10.1007/s11926-012-0307-x.

Gout and its comorbidities: implications for therapy.

Stamp LK, Chapman PT. Rheumatology (Oxford). 2013;52(1):34-44.

Improved health-related quality of life and physical function in patients with refractory chronic gout following treatment with pegloticase: evidence from phase III randomized controlled trials.

Strand V, et al. J Rheumatol. 2012;39(7):1450-1457.

Recent advances in management of gout.

Suresh E, Das P. QJM. 2012;105(5):407-417.

 

Interactive Presentation

Clinical Updates on the Management of Gout

Michael H. Pillinger, MD


Relevant Resources

Clinical Updates in Systemic Lupus Erythematosus

Improved Diagnostic and Management Strategies

Advances in Immunosupressive Therapy for Solid Organ Transplantation

Long-Term Management Strategies to Improve Patient Outcomes

Acute Management of Migraine Attacks

Overcoming Pain and Gastrointestinal Distress to Improve Patient Outcomes

Opioid-Induced Constipation

Proactive Diagnosis and Targeted Management

Chronic Obstructive Pulmonary Disease, Asthma, or Both

Differential Diagnosis and Comprehensive Management Strategies

Improving Outcomes in Chronic Obstructive Pulmonary Disease

Optimizing Maintenance Therapy Across Healthcare Settings

Managing Gout in Primary Care

Evolving Strategies for Diagnosis and Long-Term Management

Clinical Issues in Chronic Pain

Consensus and Controversies for Responsible Opioid Prescribing

Noninsulin Approaches to Managing Type 2 Diabetes

Best Practices in Combination Therapy

Hitting the Target in Type 2 Diabetes

Evolving Approaches to Insulin Based Therapy

Improving Outcomes in Rheumatoid Arthritis

Treating to Target, IL-6-Directed Therapies, and Evolving Management Algorithms

Clearing the Air

Improving Outcomes for Patients with COPD

Clinical Updates in Type 2 Diabetes

New Strategies for Insulin Replacement Therapy

How Low Do You Go?

Clinical Updates in LDL-C Management

Incretin-Based Therapies For Type 2 Diabetes

Improving Comprehensive Patient Care

Improving Outcomes in Non–24-Hour Sleep-Wake Disorder

Identifying Patients and Tailoring Therapy

Comprehensive Management of Chronic Obstructive Pulmonary Disease

Collaborative Approaches to Guideline-Concordant Patient Care

Clinical Updates in the Management of Severe Asthma

New Strategies for Individualizing Long-term Care

Comprehensive Chronic Pain Management

A Focus on Patients With Opioid-Induced Constipation

Clinical Issues in Bipolar Depression

Consensus and Controversies Across the Spectrum of Patient Presentations

Clinical Updates in Rheumatoid Arthritis

Evolving Treatment Algorithms and Expert Perspectives on Biosimilars

Going Deeper on Atopic Dermatitis

Pathophysiology to the Management of Moderate-to-Severe Disease

Caring for Patients with Severe Asthma

Evolving Best Practices to Optimize Outcomes

Looking Beneath The Surface In Atopic Dermatitis

Targeting Immune Dysregulation and Delivering Comprehensive Care

Can You Spot Axial Spondyloarthritis?

The PCP’s Role in Timely Recognition and Referral

Evolving Treatment Paradigms For Rheumatoid Arthritis

Translating Comprehensive Patient Evaluations Into Personalized Therapy

Clinical Updates in Rheumatoid Arthritis

New Perspectives on Targeting Remission and Individualizing Therapy

A Better Look at Rheumatoid Arthritis

Using Imaging to Improve Patient Outcomes

Clinical Issues in Rheumatoid Arthritis

Discussions and Debates on the Evolving Roles of Targeted Synthetic DMARDs

Advancing the Care of Severe Asthma

Differential Diagnosis, Multidisciplinary Management, and Patient Engagement

Updates in HCV Screening and Treatment

Key Issues Impacting OB/GYN Practice